Vinva Investment Management Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1968109 SYDNEY, C3

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$11,482,975

+$761,701 QoQ

Shares Held

14,862

+7.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Vinva Investment Management Ltd holds $66,411,479 across 13 Biotechnology names. REGN ranks #3 (17.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	300,405	$28,274,118
2	ALNY	Alnylam Pharmaceuticals, Inc.	36,601	$12,110,172
3	REGN	Regeneron Pharmaceuticals, Inc. This page	14,862	$11,482,975
4	VRTX	Vertex Pharmaceuticals Inc / Ma	9,531	$4,255,972
5	EXEL	Exelixis, Inc.	49,204	$2,110,359
6	JAZZ	Jazz Pharmaceuticals plc	11,142	$2,106,395
7	HALO	Halozyme Therapeutics, Inc.	32,126	$2,076,303
8	ASND	Ascendis Pharma A/S	5,694	$1,302,388

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,482,975	14,862	+7.0%	Shares	Sole	2026-05-14
2025-12-31	$10,721,274	13,890	+58.3%	Shares	Sole	2026-02-17
2025-09-30	$4,933,919	8,775	+31.3%	Shares	Sole	2025-11-13
2025-06-30	$3,508,050	6,682	+21.5%	Shares	Sole	2025-08-13
2025-03-31	$3,488,265	5,500	+45.5%	Shares	Sole	2025-05-14
2024-12-31	$2,691,895	3,779	+45.5%	Shares	Sole	2025-02-11
2024-09-30	$2,730,070	2,597	-28.9%	Shares	Sole	2024-11-14
2024-06-30	$3,838,361	3,652	-10.0%	Shares	Sole	2024-08-13
2024-03-31	$3,904,821	4,057	+9.7%	Shares	Sole	2024-05-13
2023-12-31	$3,247,916	3,698	+16.7%	Shares	Sole	2024-02-13
2023-09-30	$2,607,137	3,168	-0.3%	Shares	Sole	2023-11-13
2023-06-30	$2,283,520	3,178	-13.0%	Shares	Sole	2023-08-14
2023-03-31	$3,001,560	3,653	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.